Skip to main content
Log in

Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Camelo-Piragua S, Jansen M, Ganguly A, Kim JC, Cosper AK, Dias-Santagata D, Nutt CL, Iafrate AJ, Louis DN (2011) A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53. J Neuropathol Exp Neurol 70:110–115

    Article  PubMed  CAS  Google Scholar 

  2. Capper D, Reuss D, Schittenhelm J, Hartmann C, Bremer J, Sahm F, Harter PN, Jeibmann A, von Deimling A (2011) Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta Neuropathol 121:241–252

    Article  PubMed  Google Scholar 

  3. Capper D, Sahm F, Hartmann C, Meyermann R, von Deimling A, Schittenhelm J (2010) Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. Am J Surg Pathol 34:1199–1204

    Article  PubMed  Google Scholar 

  4. Capper D, Weissert S, Balss J et al (2010) Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 20:245–254. doi:10.1111/j.1750-3639.2009.00352.x

    Article  PubMed  CAS  Google Scholar 

  5. Capper D, Zentgraf H, Balss J, Hartmann C, Deimling A (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 118:599–601. doi:10.1007/s00401-009-0595-z

    Article  PubMed  CAS  Google Scholar 

  6. CBTRUS (2012) CBTRUS Statistical Report: primary brain and central nervous system tumors diagnosed in the United States in 2004–2008. Source: Central Brain Tumor Registry of the United States, Hinsdale, IL. Website: www.CBTRUS.org

  7. Horbinski C, Kelly L, Nikiforov YE, Durso MB, Nikiforova MN (2010) Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies. J Mol Diagn 12:487–492

    Article  PubMed  CAS  Google Scholar 

  8. Horbinski C, Kofler J, Kelly LM, Murdoch GH, Nikiforova MN (2009) Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues. J Neuropathol Exp Neurol 68:1319–1325

    Article  PubMed  CAS  Google Scholar 

  9. Horbinski C, Kofler J, Yeaney G, Camelo-Piragua S, Venneti S, Louis DN, Perry A, Murdoch G, Nikiforova M (2011) Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas. Brain Pathol 21:564–574

    Article  PubMed  CAS  Google Scholar 

  10. Kloosterhof NK, Bralten LBC, Dubbink HJ, French PJ, van den Bent MJ (2011) Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma? Lancet Oncol 12:83–91. doi:10.1016/s1470-2045(10)70053-x

    Article  PubMed  CAS  Google Scholar 

  11. Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H, Pfister S, von Deimling A, Hartmann C (2009) Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol 118:401–405

    Article  PubMed  CAS  Google Scholar 

  12. Labussiere M, Idbaih A, Wang XW et al (2010) All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2. Neurology 74:1886–1890

    Article  PubMed  CAS  Google Scholar 

  13. Preusser M, Wohrer A, Stary S, Hoftberger R, Streubel B, Hainfellner JA (2011) Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens. J Neuropathol Exp Neurol 70:715–723

    Article  PubMed  CAS  Google Scholar 

  14. Rineer J, Schreiber D, Choi K, Rotman M (2010) Characterization and outcomes of infratentorial malignant glioma: a population-based study using the Surveillance Epidemiology and End-Results database. Radiother Oncol 95:321–326. doi:10.1016/j.radonc.2010.04.007

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We wish to thank Lindsey Heathcock and Alicia Ledoux and her team for technical assistance. This work was supported in part by the Gyorkey Endowed Chair for Research and Education in Pathology.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Benjamin Ellezam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ellezam, B., Theeler, B.J., Walbert, T. et al. Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Acta Neuropathol 124, 449–451 (2012). https://doi.org/10.1007/s00401-012-1011-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-012-1011-7

Keywords

Navigation